SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041030
Filing Date
2019-11-06
Accepted
2019-11-06 16:16:37
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-10q_20190930.htm 10-Q 2207787
2 EX-10.1 mirm-ex101_471.htm EX-10.1 25237
3 EX-31.1 mirm-ex311_6.htm EX-31.1 18651
4 EX-31.2 mirm-ex312_9.htm EX-31.2 18905
5 EX-32.1 mirm-ex321_8.htm EX-32.1 9731
6 EX-32.2 mirm-ex322_7.htm EX-32.2 9747
  Complete submission text file 0001564590-19-041030.txt   6394014

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mirm-20190930.xml EX-101.INS 1051779
8 XBRL TAXONOMY EXTENSION SCHEMA mirm-20190930.xsd EX-101.SCH 52869
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mirm-20190930_cal.xml EX-101.CAL 45647
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mirm-20190930_def.xml EX-101.DEF 195536
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20190930_lab.xml EX-101.LAB 411585
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20190930_pre.xml EX-101.PRE 318449
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 191196509
SIC: 2834 Pharmaceutical Preparations